VolitionRx (VNRX) Earnings Date, Estimates & Call Transcripts → How to Make 100X on the AI Boom (From InvestorPlace) (Ad) Free VNRX Stock Alerts $0.88 +0.05 (+6.04%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Earnings SummaryLatest Earnings DateMar. 25EstimatedActual EPS (Mar. 25) -$0.11 Missed By -$0.11 Get VolitionRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for VNRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVNRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceHow to Make 100X on the AI BoomFor over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs VolitionRx Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.50) EPSNext Year EPS Consensus Estimate: ($0.33) EPSVNRX Earnings Date and InformationVolitionRx last posted its quarterly earnings results on March 25th, 2024. The medical research company reported ($0.11) EPS for the quarter. The business had revenue of $0.24 million for the quarter, compared to analyst estimates of $0.50 million. VolitionRx has generated ($0.56) earnings per share over the last year (($0.56) diluted earnings per share). Earnings for VolitionRx are expected to grow in the coming year, from ($0.50) to ($0.33) per share. Read More VolitionRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/25/2024Q4 2023-($0.11)($0.11)($0.11)$0.50 million$0.24 million11/14/2023Q3 2023($0.12)($0.11)+$0.01($0.11)$0.26 million$0.17 million 8/14/2023Q2 2023($0.13)($0.14)($0.01)($0.14)$0.29 million$0.22 million 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 millionCrypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos…11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million 11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 millionCrypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos…11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.11)($0.13)($0.02)($0.13)$0.03 million$0.03 million 8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million VolitionRx Earnings - Frequently Asked Questions When did VolitionRx announce their last quarterly earnings? VolitionRx (NYSEAMERICAN:VNRX) last announced its quarterly earning data on Monday, March 25, 2024. Learn more on VNRX's earnings history. How much revenue does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded annual revenue of $310,000.00. How much profit does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded net income of -$30.27 million. VNRX has generated -$0.56 earnings per share over the last four quarters. What is VolitionRx's EPS forecast for next year? VolitionRx's earnings are expected to grow from ($0.50) per share to ($0.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies: APYX Earnings Results NHIQ Earnings Results HCWB Earnings Results DRIO Earnings Results VASO Earnings Results RMTI Earnings Results NSPR Earnings Results OCUP Earnings Results ABIO Earnings Results CHHE Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSEAMERICAN:VNRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
